Anta Sports Expands Global Footprint With Strategic Puma Stake 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
IRVING, Texas, Oct. 12, 2016 -- HMS Holdings Corp. (NASDAQ:HMSY) today announced that Alex Michael Azar II has been appointed to the HMS Board of Directors, effective October 11, 2016. Mr. Azar is President, Lilly USA, LLC, the largest affiliate of Eli Lilly & Company (NYSE:LLY). Prior to joining Lilly, Mr. Azar was the Deputy Secretary (2005-2007) and General Counsel (2001-2005) at the U.S. Department of Health & Human Services.
“Alex Azar brings an important blend of government and industry experience to our Board,” said Bill Lucia, Chairman and CEO. “He has an informed perspective on healthcare policy which will enrich our Board dialogue. In addition, Alex has extensive experience with big data in his current role at Lilly which is particularly relevant as we expand into the care management and data analytics field with our recent acquisition of Essette.”
Prior to his service at HHS, Mr. Azar was in private legal practice. He is a graduate of Dartmouth College and the Yale Law School, and was a Law Clerk to U.S. Supreme Court Justice Antonin Scalia.
“Expenditures in government programs - whether administered by CMS, state governments or health plans – are projected to continue growing at an unsustainable level. I look forward to joining the HMS Board and utilizing my public and private healthcare experience to contribute to its strategic discussion about ongoing efforts by HMS to develop and acquire solutions for payers that help bend the cost curve,” commented Mr. Azar.
About HMS
HMS Holdings Corp., through its subsidiaries, provides coordination of benefits, payment integrity and care management solutions for payers. The Company serves state Medicaid programs; health plans, including Medicaid managed care, Medicare Advantage and group and individual health lines of business; federal government health agencies, including the Centers for Medicare & Medicaid Services and the Veterans Health Administration; government and private employers; and other healthcare payers and sponsors, including child support agencies. As a result of the Company’s services, customers recover billions of dollars annually and save billions more through the prevention of improper payments.
Investor Contact: Dennis Oakes SVP, Investor Relations [email protected] 212-857-5786 Media Contact: Francesca Marraro VP, Marketing and Communications [email protected] 212-857-5442
